BackClarus Therapeutics Holdings Overview

Clarus Therapeutics Holdings Current Assets

Clarus Therapeutics Holdings's current assets is $49M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$48.88M
↑ 73.01% YoYΔ $20.63M vs prior year quarter

Peer average

Loading

Clarus Therapeutics Holdings Current Assets History

Loading

Clarus Therapeutics Holdings vs. peers: Current Assets Comparison

Loading

Clarus Therapeutics Holdings Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Clarus Therapeutics Holdings (CRXT) FAQ

As of the most recent data (June 2022), CRXT shows a current assets of $49M. That compares with $28M in the prior-year period — up 73.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRXT's current assets is now $49M (was $28M) — a 73.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Clarus Therapeutics Holdings is outperforming or lagging.

Tracking CRXT's current assets over time shows whether Clarus Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $49M That compares with $28M in the prior-year period — up 73.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Clarus Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $49M) with ownership activity and broader fundamentals.